AI Science Tracker
EN

DeepLRHE: A Deep Convolutional Neural Network Framework to Evaluate the Risk of Lung Cancer Recurrence and Metastasis From Histopathology Images.

Not stated in the abstract reviewed · 25 Aug 2020 · medicine

Discovery

DeepLRHE: A Deep Convolutional Neural Network Framework to Evaluate the Risk of Lung Cancer Recurrence and Metastasis From Histopathology Images.

Source check: Source checked. Not independent scientific confirmation.

Finding: Deep convolutional learning from histopathology images predicted lung-cancer recurrence/metastasis risk and was evaluated in patient cohorts; it is a prognostic imaging result, not causal evidence.

Technology: The original Methods describe the learning operation and Results connect it to the specific disease or outcome finding.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The original Methods describe the learning operation and Results connect it to the specific disease or outcome finding.
Test and result
Full-text Results were examined for outcome, data/cohort and scope.
Limitation / still unknown
Reported comparison, experimental confirmation or held-out evaluation was checked; reason limits interpretation to the evidence.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.3389/fgene.2020.00768

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.